Abstract:Three plasmid constructs were prepared that express small interfering RNAs (siRNAs) targeted to sequences encoding the ribonucleoprotein member, nucleoprotein (NP) and/or PA, of influenza virus genome. The antiviral properties of siRNAs against the H5N1 strain of influenza virus were studied by evaluating their capacity to silence expression of target genes as well as their effect on influenza virus-induced apoptosis in Madin-Darby canine kidney cells, chicken embryo fibroblast cells, and embryonated chicken eggs in a transient replication model. The results demonstrated that all three siRNAs expressing plasmids efficiently transcribed the short hairpin RNAs and inhibited expression of the NP or PA proteins measured by northern blot and western blot analyses, respectively, in the transfected cells. We also found that the integrated siRNA expression plasmid pEGFP/NP+PA, which we constructed for the first time to synchronously target NP and PA segments of the influenza virus genome, could more efficiently inhibit synthesis of influenza virus detected by cytopathogenic effects, hemagglutinin, and plaque-forming unit assays in the transfected cells. Furthermore, the integrated siRNA expression plasmid pEGFP/NP+PA could remarkably interrupt the cellular apoptotic course caused by influenza virus, which protected infected cells from apoptotic damage. In contrast, a control siRNA expression plasmid, pEGFP/HK, could neither inhibit the protein expression and production of influenza virus nor interrupt the cell apoptotic course mediated by influenza virus. These results demonstrate that RNA interference (RNAi) can be used to inhibit protein expression and replication of influenza virus and that RNAi treatment holds potential as a new approach to prevent avian influenza.

795. RNA Interference of Influenza Virus Infection

Research Progress on Drug-Resistance of Influenza Virus to Neuraminidase Inhibitors

RNA Interference of Influenza Virus Production by Directly Targeting Mrna for Degradation and Indirectly Inhibiting All Viral RNA Transcription

Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection.

Use of Sirnas to Prevent and Treat Influenza Virus Infection

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

Antiviral Approaches against Influenza Virus

Progress of Influenza Viruses and Inhibitors

Influenza Virus Cell Entry and Targeted Antiviral Development

Development and Effects of Influenza Antiviral Drugs

Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza

Emerging antiviral therapies and drugs for the treatment of influenza

RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication

Construction of Influenza Virus Sirna Expression Vectors and Their Inhibitory Effects on Multiplication of Influenza Virus.

Antiviral Potential of Natural Resources against Influenza Virus Infections

Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture

Influenza: old and new threats

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery

Continuing challenges in influenza

Antiviral strategies against influenza virus: towards new therapeutic approaches

Current and novel antiviral strategies for influenza infection